MedTrace Logo

Effects of a Proactive Social Robot for Older Adults in Reducing Loneliness and Social Isolation

NCT03972787 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2021-02-05

No results posted yet for this study

Summary

This project will to evaluate whether a proactive social robot (ElliQ) has an impact on reducing social isolation and loneliness in older adults who are living alone, while also promoting independence and aging in place. To achieve this, the following research questions will be investigated:

1. How does the use of ElliQ impact the following outcomes in older adults:

* Loneliness and social isolation;
* Accessibility to and use of technology;
* Quality of life, mood, and overall well-being; and
* Caregiver experience?
2. Do particular characteristics of the older adult population influence these impacts?

Conditions

  • Loneliness
  • Mood
  • Quality of Life

Interventions

DEVICE

Proactive social robot

ElliQ, is a new type of robotic technology aimed at reducing loneliness and social isolation in older adults. It differs from other social/companion robots on the market, as it leverages artificial intelligence to create personalized and interactive experiences for the user, while also proactively offering prompts (such as reminding the user to stay hydrated) and suggesting and initiating various activities for the user (such as offering to play a game). This social companion adapts to the personalities and interests of the older adult, creating a personalized experience and recommending content the user may enjoy such as news, music, TED talks, and cognitive games.

Sponsors & Collaborators

  • Jewish Senior Living Group

    collaborator UNKNOWN

  • Intuition Robotics

    collaborator UNKNOWN

  • Baycrest

    lead OTHER

Principal Investigators

  • Allison B Sekuler, PhD · Baycrest

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2020-01-31
Completion
2020-07-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03972787 on ClinicalTrials.gov